-
公开(公告)号：US20200308296A1
公开(公告)日：2020-10-01
申请号：US16830585
申请日：2020-03-26
Applicant: Janssen Biotech, Inc.
Inventor： Rajesh Bandekar , Pamela Clemens , Christoph Heuck , Ming Qi , Zhilong Yuan
IPC: C07K16/28 , A61K38/47 , A61K31/454 , A61K31/573 , A61K47/26 , A61K47/22 , A61K47/18 , A61P35/00
Abstract: The present invention relates to clinically proven subcutaneous pharmaceutical compositions comprising anti-CD38 antibodies and methods of their uses in combination with pomalidomide and dexamethasone.
-
公开(公告)号：US20230330224A1
公开(公告)日：2023-10-19
申请号：US18300288
申请日：2023-04-13
Applicant: Janssen Biotech, Inc.
Inventor： Rajesh Bandekar , Pamela Clemens , Christoph Heuck , Ming Qi , Zhilong Yuan
IPC: A61K9/00 , A61K39/395 , A61K31/573 , A61K31/69 , A61K38/47 , A61P35/00
CPC classification number: A61K39/3955 , A61K9/0019 , A61K9/0053 , A61K31/573 , A61K31/69 , A61K38/47 , A61P35/00 , C12Y302/01035
Abstract: The present invention relates to clinically proven subcutaneous pharmaceutical compositions comprising anti-CD38 antibodies and methods of their uses in combination with bortezomib and dexamethasone.
-
公开(公告)号：US20200330593A1
公开(公告)日：2020-10-22
申请号：US16830909
申请日：2020-03-26
Applicant: Janssen Biotech, Inc.
Inventor： Rajesh Bandekar , Pamela Clemens , Christoph Heuck , Ming Qi , Zhilong Yuan
IPC: A61K39/395 , A61K38/47 , A61P35/00 , A61K9/00
Abstract: The present invention relates to clinically proven subcutaneous pharmaceutical compositions comprising anti-CD38 antibodies and methods of their uses in combination with bortezomib, melphalan and prednisone.
-
4.发明申请公开(公告)号：US20200308297A1
公开(公告)日：2020-10-01
申请号：US16830629
申请日：2020-03-26
Applicant: Janssen Biotech, Inc.
Inventor： Rajesh Bandekar , Pamela Clemens , Christoph Heuck , Ming Qi , Zhilong Yuan
Abstract: The present invention relates to clinically proven subcutaneous pharmaceutical compositions comprising anti-CD38 antibodies and their uses.
-
公开(公告)号：US20250109198A1
公开(公告)日：2025-04-03
申请号：US18797622
申请日：2024-08-08
Applicant: Janssen Biotech, Inc.
Inventor： Christoph Heuck , Colleen Kane , Marie-Anne Damiette Smit
Abstract: Described herein are approved products and methods of using approved products for treating relapsed or refractory multiple myeloma in a patient. Also described herein are methods of selling or offering for sale an approved product.
-
Patent Agency Ranking
公开(公告)号：US20230250174A1
公开(公告)日：2023-08-10
申请号：US18300248
申请日：2023-04-13
Applicant: Janssen Biotech, Inc.
Inventor： Rajesh Bandekar , Pamela Clemens , Christoph Heuck , Ming Qi , Zhilong Yuan
IPC: C07K16/28 , A61P35/00 , A61K31/454 , A61K47/26 , A61K47/18 , A61K31/573
CPC classification number: C07K16/2818 , A61P35/00 , A61K31/454 , A61K47/26 , A61K47/183 , A61K31/573 , A61K45/06
Abstract: The present invention relates to clinically proven subcutaneous pharmaceutical compositions comprising anti-CD38 antibodies and methods of their uses in combination with lenalidomide and dexamethasone.
-
公开(公告)号：US20230295333A1
公开(公告)日：2023-09-21
申请号：US18300683
申请日：2023-04-14
Applicant: Janssen Biotech, Inc.
Inventor： Rajesh Bandekar , Pamela Clemens , Christoph Heuck , Ming Qi , Zhilong Yuan
IPC: C07K16/28 , A61K38/47 , A61K31/454 , A61K31/573 , A61K47/26 , A61K47/22 , A61P35/00 , A61K47/18
CPC classification number: C07K16/2896 , A61K38/47 , A61K31/454 , A61K31/573 , A61K47/26 , A61K47/22 , A61P35/00 , A61K47/183 , A61K2039/542
Abstract: The present invention relates to clinically proven subcutaneous pharmaceutical compositions comprising anti-CD38 antibodies and methods of their uses in combination with pomalidomide and dexamethasone.
-
8.发明公开公开(公告)号：US20230348615A1
公开(公告)日：2023-11-02
申请号：US18348384
申请日：2023-07-07
Applicant: Janssen Biotech, Inc.
Inventor： Rajesh Bandekar , Pamela Clemens , Christoph Heuck , Ming Qi , Zhilong Yuan
CPC classification number: C07K16/2896 , A61K38/47 , A61K47/183 , A61K47/22 , A61K47/26 , A61P35/00 , C12N9/2402 , A61K47/10 , A61K45/06
Abstract: The present invention relates to clinically proven subcutaneous pharmaceutical compositions comprising anti-CD38 antibodies and their uses.
-
公开(公告)号：US20230277660A1
公开(公告)日：2023-09-07
申请号：US18300183
申请日：2023-04-13
Applicant: Janssen Biotech, Inc.
Inventor： Rajesh Bandekar , Pamela Clemens , Christoph Heuck , Ming Qi , Zhilong Yuan
IPC: A61K39/395 , A61K38/47 , A61K9/00 , A61P35/00
CPC classification number: A61K39/3955 , A61K9/0019 , A61K9/0053 , A61K38/47 , A61P35/00 , C12Y302/01035 , A61K2039/545
Abstract: The present invention relates to clinically proven subcutaneous pharmaceutical compositions comprising anti-CD38 antibodies and methods of their uses in combination with bortezomib, melphalan and prednisone.
-
公开(公告)号：US20200316197A1
公开(公告)日：2020-10-08
申请号：US16830810
申请日：2020-03-26
Applicant: Janssen Biotech, Inc.
Inventor： Rajesh Bandekar , Pamela Clemens , Christoph Heuck , Ming Qi , Zhilong Yuan
IPC: A61K39/395 , A61K38/47 , A61K9/00 , A61P35/00 , A61K31/69 , A61K31/573
Abstract: The present invention relates to clinically proven subcutaneous pharmaceutical compositions comprising anti-CD38 antibodies and methods of their uses in combination with bortezomib and dexamethasone.
-
-
-
-
-
-
-
-
-
Search Results
11
records
(took 0.012 seconds)
